U.S. Biotech Stock News

UCB reported that its arthritis drug Bimzelx outperformed AbbVie’s Skyrizi in a head to head clinical trial in psoriatic arthritis. The trial result introduces a new competitive challenge for one of NYSE:ABBV’s key immunology products in an important inflammatory disease indication. Early commentary points to limited immediate sales impact, and investors are watching how this could influence future positioning of Skyrizi within psoriatic arthritis. For context, AbbVie, ticker NYSE:ABBV, has...

In recent days, DNOW Inc. has faced pressure after disappointing fourth-quarter 2025 results, a significant loss, and the launch of a Rosen Law Firm investigation into potentially misleading business information, alongside a reduction in holdings by major shareholder Barrow Hanley Mewhinney & Strauss LLC. At the same time, DNOW is pursuing growth through its MRC Global deal and integration efforts, even as concerns mount over substandard operating margins, declining earnings per share and...

If you are wondering whether BETA Technologies at around US$16.65 is a bargain or a value trap, you are not alone. This article is here to unpack what the current price might be implying. The stock has had a rough patch recently, with a 13.6% decline over the last 7 days, a 14.1% decline over the last 30 days, and a 39.1% decline year to date, which can change how the market views both its potential and its risk. Recent news coverage has focused on BETA Technologies as part of broader...

Earlier in March 2026, Evergy, Inc. completed a US$349.96 million fixed‑income issuance of 4.250% senior unsecured notes due March 15, 2029, priced at 99.988% of principal and featuring a fixed coupon and callable structure. This bond deal, together with Evergy’s broader fixed‑rate notes program, adds financial flexibility that may influence how it funds planned grid and generation investments. With Evergy’s new US$350 million bond issuance in place, we’ll examine how this added funding...

Earlier this week, Truist Securities reaffirmed its positive view on Sila Realty Trust after the company posted fourth-quarter 2025 results with revenue modestly ahead of forecasts but earnings per share slightly behind expectations. The research update emphasized that Sila’s fully leased triple-net healthcare portfolio and cash flow coverage of its dividend remain central to the REIT’s appeal despite higher interest costs and isolated vacancies. With Truist spotlighting the resilience of...

If you are wondering whether Watsco’s current share price lines up with its underlying worth, you are not alone. This article will walk through what the numbers actually say about value. Watsco’s share price closed at US$368.39 recently, with returns of 6.1% year to date, a 25.5% decline over the past year, and gains of 34.7% over 3 years and 67.0% over 5 years. This gives a mixed picture for anyone trying to assess opportunity and risk. Recent price moves, including a 6.3% decline over the...

NVIDIA and Nebius Group N.V. recently announced a partnership under which NVIDIA will invest US$2.00 billion via pre-funded warrants, deepening collaboration across AI factory design, infrastructure deployment, and software to support Nebius’s plan to deploy over 5 gigawatts of AI capacity by 2030. The deal gives Nebius early access to NVIDIA’s next-generation Rubin platform, Vera CPUs, and BlueField storage systems, effectively tying the company’s hyperscale AI cloud roadmap directly into...

If you are wondering whether Check Point Software Technologies is attractively priced or not, this article walks through the key numbers so you can judge the stock's value with confidence. The share price last closed at US$153.65, with returns of 7% decline over 7 days, 6.6% decline over 30 days, 15.1% decline year to date, 31.7% decline over 1 year, 19.0% over 3 years and 31.7% over 5 years. This raises fair questions about how the market currently views its growth prospects and...

Why 1st Source Stock Is Drawing Investor Attention 1st Source (SRCE) is back on some investors’ radar after a recent stretch of mixed returns, including a small 1 day pullback and gains over the past 3 months and year. See our latest analysis for 1st Source. Recent trading has been relatively steady, with a 7 day share price return of 0.5% and a 90 day share price return of 3.0%, while the 1 year total shareholder return of 13.8% suggests momentum has been building over a longer horizon. If...

Universal Health Services (NYSE:UHS) has agreed to acquire virtual behavioral health provider Talkspace in a deal valued at about US$835 million. The transaction is structured as a definitive agreement and is expected to close later in 2026, subject to customary approvals. Talkspace brings a nationwide digital platform focused on behavioral health, which UHS plans to integrate into its existing services. For you as an investor, this move puts a spotlight on how NYSE:UHS is approaching...

What GATX’s Recent Returns Tell You Right Now GATX (GATX) has given investors a mixed ride recently, with the stock down about 0.8% over the past day and 10.8% over the past month, while the past 3 months are roughly flat. See our latest analysis for GATX. Zooming out, the recent 1 month share price pullback and 7 day share price weakness sit against a share price of US$168.50 and a 1 year total shareholder return of 11.13%. The 5 year total shareholder return of 108.54% points to momentum...

Why Synchrony Financial is on investors’ radar Synchrony Financial (SYF) has drawn attention after a period of weak recent returns, including a 12.5% decline over the past month and a 24.3% decline over the past 3 months. Against that backdrop, investors are revisiting the stock’s fundamentals, including revenue of US$9.76b, net income of US$3.47b, and a value score of 6, to reassess how the current price lines up with the underlying business. See our latest analysis for Synchrony...

Jobs data shock and private credit jitters weigh on Houlihan Lokey (HLI) Houlihan Lokey (HLI) has come under pressure after weak US February jobs data sparked a sell-off in financial stocks, while JPMorgan Chase's tighter lending to private credit providers added further sector stress. See our latest analysis for Houlihan Lokey. Those headline shocks have hit recent momentum hard, with a 7 day share price return of 7.7% and a 30 day decline of 18.1%. The year to date move of 20.9% contrasts...

In early 2026, ComEd, an Exelon subsidiary, rolled out a Low-Income Discount program that has already enrolled about 240,000 customers while the Federal Energy Regulatory Commission approved five transmission security agreements with data center developers to shield existing customers from additional transmission costs. Together with analyst recognition of Exelon’s strong recent earnings and multi‑year capital investment plans, these developments highlight how regulatory support and targeted...

What Nucor’s Recent Share Performance Signals for Investors Nucor (NUE) has recently seen its share price under pressure, with a 1 day return of 1.32%, a 7 day decline of 3.12%, and a month drop of 15.91%. Over the past 3 months, the stock is down 0.99%. Its 1 year total return stands at 25.78%, and its 5 year total return at 147.79%, putting the latest moves in a longer term context. See our latest analysis for Nucor. The recent 30 day share price return of a 15.91% decline suggests momentum...

Why Codexis Is Back on Investors’ Radar Codexis (CDXS) has drawn fresh attention after reporting fourth quarter 2025 results, with revenue of US$38.92 million and net income of US$9.6 million, alongside new full year 2026 revenue guidance. The company also recently signed an agreement to manufacture 50 grams of siRNA for a pharmaceutical partner using its ECO Synthesis platform, adding a commercial data point around its RNA manufacturing capabilities. See our latest analysis for Codexis. At a...

Earlier this week, Six Flags Entertainment announced a partnership naming three-time Super Bowl champion Travis Kelce as a brand ambassador for its 2026 season, giving the company rights to use his name, image, and digital content across social media, broadcast, streaming, and in-park marketing. This collaboration underscores Six Flags’ push to refresh its brand and deepen fan engagement by linking its parks to a high-profile NFL personality with broad mainstream appeal. We’ll now examine...

In recent days, Williams Companies outlined plans to expand its natural gas infrastructure and explore upstream asset purchases to supply power-hungry data centers and AI-related facilities, while also issuing 2026 EBITDA guidance, growth capital plans, and announcing a 5% increase in its annual dividend to US$2.10 per share. At the same time, Williams has drawn attention from major ETFs, hosted executives at high-profile industry forums, and seen insider share sales and updated analyst...

Installed Building Products recently reported strong earnings, with growth in its heavy commercial segment helping offset weaker installation-related revenues amid ongoing single-family housing softness and uncertainty in private non-residential development. At the same time, analysts have kept cautious ratings and insider selling has continued, underscoring a tension between operational resilience and perceived sector and cost risks. We’ll now examine how this heavy commercial-driven...

Why Expeditors stock is back in focus Expeditors International of Washington (EXPD) is drawing fresh attention after authorizing a new share repurchase program of up to US$3b and reporting Q4 2025 earnings that exceeded EPS and revenue forecasts. See our latest analysis for Expeditors International of Washington. Despite a Q4 2025 earnings beat and the new US$3b buyback authorization, the 30 day share price return of 11.95% and year to date share price return of 6.13% are weaker, while the 1...

MGE Energy recently reported stronger-than-expected earnings with solid revenue growth, brought new clean energy assets online, extended its multi-decade dividend-raise streak, and saw director James G. Berbee increase his shareholding through an insider purchase. Together with an at-the-market equity program and fresh analyst commentary on renewables and data center-related demand, these moves point to a company emphasizing financial flexibility, long-term capital returns, and board-level...

In the most recent quarter, Masco reported revenue of US$1.79 billion, a 1.9% year-on-year decline that missed analyst expectations by 1.5%, underscoring a softer period amid cyclical pressures in home construction materials. Behind the headline miss, Masco’s lagging organic revenue growth, flat earnings per share versus peers, and recent need to reassess product, pricing, or go-to-market strategy raise questions about its competitive position even as dividend growth remains a key...

Why nVent Electric (NVT) Is On Investors’ Radar Today nVent Electric (NVT) has drawn attention after a strong 1 year total return of 95.9%, putting its recent share performance front and center for investors reviewing capital goods names. See our latest analysis for nVent Electric. At a share price of $109.93, nVent Electric has seen short term share price gains, with a 1 day return of 1.91% and 7 day return of 3.69%. Its 1 month share price return shows a 2.50% decline, which contrasts with...

Why Martin Marietta Materials is on investors’ radar today Martin Marietta Materials (MLM) has drawn fresh attention after recent trading left the shares about 12% lower over the past month and roughly 7% lower over the past 3 months. See our latest analysis for Martin Marietta Materials. While the recent 30 day and 90 day share price returns of 11.77% and 7.08% declines suggest fading short term momentum, the 1 year and 3 year total shareholder returns of 22.92% and 85.25% highlight a...